Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inbal Houri

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinics in Liver Disease|November 9, 2023
Primary Biliary Cholangitis: PathophysiologyInbal Houri, Gideon M Hirschfield
Journal of Clinical Medicine|October 13, 2021
Real-World Management of Patients with Primary Biliary Cholangitis-A Retrospective Study from a Tertiary Medical Center in IsraelEyal Yehezkel, Inbal Israel, Inbal Houri, et al.
World Journal of Gastroenterology|September 14, 2020
Emergency department targeted screening for hepatitis C does not improve linkage to careInbal Houri, Noya Horowitz, Helena Katchman, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 14, 2021
Repetitive amiodarone administration causes liver damage via adipose tissue ER stress-dependent lipolysis, leading to hepatotoxic free fatty acid accumulationEinav Hubel, Sigal Fishman, Minna Holopainen, et al.
Hepatology Communications|September 29, 2025
High biochemical remission rates in patients with primary biliary cholangitis treated with "triple" anticholestatic therapyGuilherme G L Cançado, Bo Chen, Madeline Cameron, et al.
International Journal of Environmental Research and Public Health|November 26, 2022
Barriers and Facilitators of Hepatitis C Care in Persons Coinfected with Human Immunodeficiency VirusNir Bar, Noa Bensoussan, Liane Rabinowich, et al.
Journal of Hepatology|April 23, 2021
Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipientsLiane Rabinowich, Ayelet Grupper, Roni Baruch, et al.
Diabetology & Metabolic Syndrome|October 20, 2015
Implementation of guidelines for metabolic syndrome control in kidney transplant recipients: results at a single centerInbal Houri, Keren Tzukert, Irit Mor-Yosef Levi, et al.
BMC Infectious Diseases|April 5, 2020
Ombitasvir/paritaprevir/ritonavir & dasabuvir ± ribavirin following protease inhibitors failure - a prospective multi-centre trialLiat Deutsch, Inbal Houri, Ziv Ben-Ari, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 18, 2021
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virusAyelet Grupper, Liane Rabinowich, Doron Schwartz, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinics in Liver Disease|November 9, 2023
Primary Biliary Cholangitis: PathophysiologyInbal Houri, Gideon M Hirschfield
Journal of Clinical Medicine|October 13, 2021
Real-World Management of Patients with Primary Biliary Cholangitis-A Retrospective Study from a Tertiary Medical Center in IsraelEyal Yehezkel, Inbal Israel, Inbal Houri, et al.
World Journal of Gastroenterology|September 14, 2020
Emergency department targeted screening for hepatitis C does not improve linkage to careInbal Houri, Noya Horowitz, Helena Katchman, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 14, 2021
Repetitive amiodarone administration causes liver damage via adipose tissue ER stress-dependent lipolysis, leading to hepatotoxic free fatty acid accumulationEinav Hubel, Sigal Fishman, Minna Holopainen, et al.
Hepatology Communications|September 29, 2025
High biochemical remission rates in patients with primary biliary cholangitis treated with "triple" anticholestatic therapyGuilherme G L Cançado, Bo Chen, Madeline Cameron, et al.
International Journal of Environmental Research and Public Health|November 26, 2022
Barriers and Facilitators of Hepatitis C Care in Persons Coinfected with Human Immunodeficiency VirusNir Bar, Noa Bensoussan, Liane Rabinowich, et al.
Journal of Hepatology|April 23, 2021
Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipientsLiane Rabinowich, Ayelet Grupper, Roni Baruch, et al.
Diabetology & Metabolic Syndrome|October 20, 2015
Implementation of guidelines for metabolic syndrome control in kidney transplant recipients: results at a single centerInbal Houri, Keren Tzukert, Irit Mor-Yosef Levi, et al.
BMC Infectious Diseases|April 5, 2020
Ombitasvir/paritaprevir/ritonavir & dasabuvir ± ribavirin following protease inhibitors failure - a prospective multi-centre trialLiat Deutsch, Inbal Houri, Ziv Ben-Ari, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 18, 2021
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virusAyelet Grupper, Liane Rabinowich, Doron Schwartz, et al.
Pageof 2